Myopericarditis with Significant Left Ventricular Dysfunction Following COVID-19 Vaccination: A Case Report
Bartlett VL, Thomas A, Hur DJ, Malm B. Myopericarditis with Significant Left Ventricular Dysfunction Following COVID-19 Vaccination: A Case Report. American Journal Of Case Reports 2021, 22: e934066-1-e934066-6. PMID: 34795198, PMCID: PMC8611472, DOI: 10.12659/ajcr.934066.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsAdultBNT162 VaccineCOVID-19COVID-19 VaccinesHumansMaleMiddle AgedPandemicsSARS-CoV-2VaccinationVentricular Dysfunction, LeftConceptsSignificant left ventricular dysfunctionLeft ventricular dysfunctionCOVID-19 vaccinationVentricular dysfunctionCOVID-19 vaccineCase reportNon-steroidal anti-inflammatory treatmentBNT162b2 COVID-19 vaccineAdverse effectsGreater cardiac dysfunctionAnti-inflammatory treatmentRare adverse effectMiddle-aged patientsSafety of vaccinesMiddle-aged menEmergency use authorizationMyopericarditis casesAdverse eventsVentricular functionCardiac dysfunctionSecond doseVaccinationMyopericarditisDysfunctionVaccine